Like so many seasoned industry professionals, we eagerly seek thought leader perspectives — on the current biopharma industry landscape; the…

Sadly, another summer is coming to a close. If you have school-aged kids at home, you are undoubtedly already taking steps to shake them out of…

Coming up the ranks in various roles, I remember feeling frustrated at times when leadership would not “decide” or “give direction.” We were all…

Regardless of your company or drug development stage, congress events are critical undertakings; they represent both a substantial opportunity and a…

Many of our clients are emerging companies striving towards their first clinical development program in anticipation of delivering on a promise to…

What is the difference between strategic thinking in quantifying the future and Excel gymnastics? This was a distinction I needed to learn in my…

It was March 2020 when I wrote the first sentences of issue #30 of this e-conversation. At the time, I acknowledged the WHO’s declaration that…

When biopharma executives or business development leaders think about developing their “partnering story,” the focus is often on the innovation.…

When it comes to patient recruitment and retention for clinical trials, the bottom line is simply this: It is important and challenging in all…